Cargando…
Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655443/ https://www.ncbi.nlm.nih.gov/pubmed/37974240 http://dx.doi.org/10.1186/s40337-023-00926-5 |
| _version_ | 1785147949046562816 |
|---|---|
| author | Dixon, Laura Bartel, Sara Brown, Victoria Ali, Sarrah I. Gamberg, Susan Murphy, Andrea Brewer, Katherine L. McElroy, Susan L. Kaplan, Allan Nunes, Abraham Keshen, Aaron R. |
| author_facet | Dixon, Laura Bartel, Sara Brown, Victoria Ali, Sarrah I. Gamberg, Susan Murphy, Andrea Brewer, Katherine L. McElroy, Susan L. Kaplan, Allan Nunes, Abraham Keshen, Aaron R. |
| author_sort | Dixon, Laura |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10655443 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106554432023-11-16 Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa Dixon, Laura Bartel, Sara Brown, Victoria Ali, Sarrah I. Gamberg, Susan Murphy, Andrea Brewer, Katherine L. McElroy, Susan L. Kaplan, Allan Nunes, Abraham Keshen, Aaron R. J Eat Disord Correction BioMed Central 2023-11-16 /pmc/articles/PMC10655443/ /pubmed/37974240 http://dx.doi.org/10.1186/s40337-023-00926-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Dixon, Laura Bartel, Sara Brown, Victoria Ali, Sarrah I. Gamberg, Susan Murphy, Andrea Brewer, Katherine L. McElroy, Susan L. Kaplan, Allan Nunes, Abraham Keshen, Aaron R. Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa |
| title | Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa |
| title_full | Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa |
| title_fullStr | Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa |
| title_full_unstemmed | Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa |
| title_short | Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa |
| title_sort | correction: secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655443/ https://www.ncbi.nlm.nih.gov/pubmed/37974240 http://dx.doi.org/10.1186/s40337-023-00926-5 |
| work_keys_str_mv | AT dixonlaura correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT bartelsara correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT brownvictoria correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT alisarrahi correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT gambergsusan correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT murphyandrea correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT brewerkatherinel correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT mcelroysusanl correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT kaplanallan correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT nunesabraham correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa AT keshenaaronr correctionsecondaryoutcomesandqualitativefindingsofanopenlabelfeasibilitytrialoflisdexamfetaminedimesylateforadultswithbulimianervosa |